ACTI — Active Biotech AB publ Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK224.35m
- SEK192.68m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -34.1 | -32.2 | -49.8 | -58.4 | -45.8 |
Non-Cash Items | 0.867 | 1.9 | 1.56 | 2.19 | 1.85 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.55 | -1.87 | 2.1 | 1.34 | -1.79 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -35.8 | -32.2 | -46.2 | -54.9 | -45.7 |
Capital Expenditures | — | — | — | -0.245 | 0 |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 275 | 0 | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | 275 | 0 | — | -0.245 | 0 |
Financing Cash Flow Items | 0 | — | -2.15 | -1.31 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -205 | -1.25 | 73.1 | 43.8 | 40.2 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 34.1 | -33.5 | 26.9 | -11.3 | -5.58 |